|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2000-9-20
|
|
pubmed:abstractText |
We report the 12 months follow-up of the patients who participated in the Viradapt study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
65-70
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10846595-Anti-HIV Agents,
pubmed-meshheading:10846595-Drug Resistance, Microbial,
pubmed-meshheading:10846595-Drug Therapy, Combination,
pubmed-meshheading:10846595-Follow-Up Studies,
pubmed-meshheading:10846595-Genotype,
pubmed-meshheading:10846595-HIV Infections,
pubmed-meshheading:10846595-HIV Protease,
pubmed-meshheading:10846595-HIV Reverse Transcriptase,
pubmed-meshheading:10846595-HIV-1,
pubmed-meshheading:10846595-Humans,
pubmed-meshheading:10846595-Mutation,
pubmed-meshheading:10846595-RNA, Viral,
pubmed-meshheading:10846595-Reverse Transcriptase Inhibitors,
pubmed-meshheading:10846595-Treatment Failure
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up.
|
|
pubmed:affiliation |
Department of Infectious Diseases, Nice University Hospital, France. clevenbergh.ph@easynet.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
